Glenmark Pharmaceuticals

Aug 28, 2015 at 09:28 | Source: Moneycontrol.com
Here are the 15 midcaps which gain 4-25 percent in the last one month (July 27-August 27).
Aug 26, 2015 at 11:35 | Source: CNBC-TV18
In an interview with CNBC-TV18, Deven Choksey, MD at KR Choksey Investment Managers says NBFCs, private sector banks and large cap PSU banks are more attractive right now.
Aug 26, 2015 at 09:14 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that pharmaceutical is a buying opportunity.
Aug 24, 2015 at 21:08 | Source: PTI
Teneligliptin, a new third generation oral anti-diabetic agent, is used for the management of Type 2 Diabetes Mellitus. Glenmark has launched this molecule under two brands, Ziten and Zita Plus, at Rs 19.90 per tablet.
Aug 24, 2015 at 11:48 | Source: Moneycontrol.com
The stock rallied 56 percent in the last six months. The brokerage believes Glenmark is fully valued at its target September 2017 P/E of 21x.
Aug 21, 2015 at 09:57 | Source: CNBC-TV18
Rajat Bose of rajatkbose.com is of the view that Glenmark Pharma is a strong counter as the stock can head higher and test Rs 1253.
Aug 21, 2015 at 09:16 | Source: CNBC-TV18
Although fundamentally nothing has changed, Bank Nifty got hit by fears of payment banks eating into deposits of big banks, says Deven Choksey. He says market in general has fallen because of rupee decline which is chasing out hot money.
Aug 20, 2015 at 16:17 | Source: CNBC-TV18
Anmol Ganjoo of JM Financial likes Divis Laboratories and Torrent Pharma from the pharma space.
Aug 20, 2015 at 16:10 | Source: CNBC-TV18
In an interview with CNBC-TV18's Anuj Singhal and Ekta Batra, Surajit Pal, Pharma Analyst, Prabhudas Lilladher, discussed recent developments in the pharma sector and outlined his view on various stocks.
Aug 20, 2015 at 15:37 | Source: CNBC-TV18
Anmol Ganjoo of JM Financial says Lupin remains his top pick on perfect execution track records. He also says, sectoral tailwinds will help Sun Pharma, though Ranbaxy benefits are over-rated and medicines super-priced.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

9165 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

9165 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

9165 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

9165 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd 2014

BSE/NSE Announcer

Platinum Member

9165 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th 2014

adviserbola

Platinum Member

387 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th 2014

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th 2014

Amrita Gaba

New Member

413 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th 2014

BSE/NSE Announcer

Platinum Member

9165 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.